From October 3, 2022 to December 31, 2022, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 153,169,445 shares, representing 2.71% for $6,697.75 million under the buyback announced on December 14, 2018.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.24 USD | +1.71% | +3.77% | -2.04% |
08:01pm | Sector Update: Health Care Stocks Slipping Wednesday Afternoon | MT |
07:48pm | Pfizer Agrees to Settle 10,000 Zantac Lawsuits Over Alleged Cancer Risks, Bloomberg Reports | DJ |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.93% | 157B | |
+33.05% | 700B | |
-4.93% | 358B | |
+18.84% | 330B | |
+3.48% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+6.02% | 161B | |
+3.70% | 124B |
- Stock Market
- Equities
- PFE Stock
- News Pfizer, Inc.
- Tranche Update on Pfizer Inc.'s Equity Buyback Plan announced on December 14, 2018.